ELAVL1 and kidney disorder: Previous studies, along with ours, have shown that inhibiting HuR significantly reduces NF-kB signaling, nucleotide-binding oligomerization domain 2 (NOD2) or IL-17-mediated inflammation, and Nox2- or Nox4-mediated oxidative stress in kidney diseases [4,10,34,35].